A person’s risk of developing diseases such as cancer may be influenced by thousands of genetic differences. Single DNA differences, known as monogenic mutations, only have a small effect on risk, but when hundreds or thousands of these small risks are calculated, this is known as Polygenic Risk Score (PRS). It combines information from multiple genetic variants into a single score that can be used to examine a person’s risk.
In this podcast, we talk to oncologist, Founder and CEO of Antegenes, Dr Peeter Padrik about polygenic risk score, and its benefit and use in personalised healthcare management.
Find out how advances in this field is helping healthcare professionals use personalised prevention approaches for common conditions such as cancer and heart disease in a more precise and personalised way for more effective cancer prevention.
Listen now >>